Az utóbbi két évtizedben a katéterablatiós technológia és az ablatiós stratégiák fejlődésével jelentős előrelépés történt a kamrai tachycardiák ablatiós kezelésében. Jelen összefoglaló közlemény célja a kamrai ritmuszavarok aktuális katéterablatiós kezelésének áttekintő ismertetése. A szerzők részletezik a katéterablatiós kezelés technikai alapjait, a kamrai tachycardiák ablatiós kezelésének javallatait és ellenjavallatait, a beavatkozás előtti és az azt követő vizsgálatokat. Ezt követően a kamrai tachycardiák csoportosításán keresztül az egyes típusok katéteres ablatiójának jellemzőit ismertetik. Ezzel párhuzamosan kitérnek az adott ritmuszavar kezelésével kapcsolatos eredményekre is. Összegzésképpen kiemelik, hogy a katéteres ablatio sikeresen alkalmazható eszközös beavatkozás a kamrai tachycardiák kezelésében. Megfelelő javallat esetén a kezelést lehetőleg minél korábban be kell iktatni a terápiás stratégiába. Orv. Hetil., 2015, 156(25), 995–1002.
Prystowsky, E. N., Padanilam, B. J., Joshi, S., et al.: Ventricular arrhythmias in the absence of structural heart disease. J. Am. Coll. Cardiol., 2012, 59(20), 1733–1744.
Jacobson, J. T., Weiner, J. B.: Management of ventricular tachycardia in patients with structural heart disease. Cardiovasc. Ther., 2010, 28(5), 255–263.
Harken, A. H., Horowitz, L. N., Josephson, M. E.: The surgical treatment of ventricular tachycardia. Ann. Thorac. Surg., 1980, 30(5), 499–508.
Hartzler, G. O.: Electrode catheter ablation of refractory focal ventricular tachycardia. J. Am. Coll. Cardiol., 1983, 2(6), 1107–1113.
Santangeli, P., Infusino, F., Sgueglia, G. A., et al.: Ventricular late potentials: a critical overview and current applications. J. Electrocardiol., 2008, 41(4), 318–324.
Avitall, B., Khan, M., Krum, D. J., et al.: Physics and engineering of transcatheter cardiac tissue ablation. J. Am. Coll. Cardiol., 1993, 22(3), 921–932.
Aliot, E. M., Stevenson, W. G., Almendral-Garrote, J. M., et al.: EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace, 2009, 11(6), 771–817.
Pedersen, C. T., Kay, G. N., Kalman, J., et al.: EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace, 2014, 16(9), 1257–1283.
Prystowsky, E. N.: Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator. Rev. Cardiovasc. Med., 2001, 2(4), 197–205.
Moss, A. J., Greenberg, H., Case, R. B., et al.: Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation, 2004, 110(25), 3760–3765.
Bollmann, A., Husser, D., Cannom, D. S.: Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Am. J. Cardiovasc. Drugs, 2005, 5(6), 371–378.
Stewenson, W. G.: Current treatment of ventricular arrhythmias: state of the art. Heart Rhythm, 2013, 10(12), 1919–1926.
Mihálcz, A., Tahin, T., Szili-Török, T.: Electroanatomical mapping systems in catheter ablation of cardiac arrhythmias. [Elektroanatómiai térképező rendszerek a ritmuszavarok katéterablatiós kezelésében.] Orv. Hetil., 2008, 149(25), 1155–1160. [Hungarian]
Tanner, H., Hindricks, G., Volkmer, M., et al.: Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-Study. J. Cardiovasc. Electrophysiol., 2010, 21(1), 47–53.
Akca, F., Önsesveren, I., Jordaens, L., et al.: Safety and efficacy of the remote magnetic navigation for ablation of ventricular tachycardias – a systematic review. J. Interv. Card. Electrophysiol., 2012, 34(1), 65–71.
Roguin, A., Schwitter, J., Vahlhaus, C., et al.: Magnetic resonance imaging in inviduals with cardiovascular implantable electronic devices. Europace, 2008, 10(3), 336–346.
Clayton, B., Roobottom, C., Morgan-Hughes, G.: Assessment of the myocardium with cardiac computed tomography. Eur. Heart J. Cardiovasc. Imaging, 2014, 15(6), 603–609.
Matsudaira, K., Nakagawa, H., Wittkampf, F. H., et al.: High incidence of thrombus formation without impedance rise during radiofrequency ablation using electrode temperature control. Pacing Clin. Electrophysiol., 2003, 26(5), 1227–1237.
Jacobson, J. T., Weiner, J. B.: Management of ventricular tachycardia in patients with structural heart disease. Cardiovasc. Ther., 2010, 28(5), 255–263.
Stevenson, W. G.: Ventricular scars and ventricular tachycardia. Trans. Am. Clin. Climatol. Assoc., 2009, 120, 403–412.
Kuck, K. H., Schaumann, A., Eckardt, L., et al.: Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet, 2010, 375(9708), 31–40.
Haqquani, H. M., Marchlinski, F. E.: Electrophysiologic substrate underlying postinfarction ventricular tachycardia: characterization and role in catheter ablation. Heart Rhythm, 2009, 6(8 Suppl.), S70–S76.
Campos, B., Jauregui, M. E., Marchlinski, F. E., et al.: Use of a novel fragmentation map to identify the substrate for ventricular tachycardia in postinfarction cardiomyopathy. Heart Rhythm, 2015, 12(1), 95–103.
Josephson, M. E.: Clinical cardiac electrophysiology: Techniques and interpretations. 4th ed. Lippincott Williams and Wilkins, Philadelphia, 2008.
Meyer, C., Martinek, M., Pürerfellner, H.: Katheterablation ventrikulärer Tachykardien. Austr. J. Cardiol., 2011, 18(3–4), 87–95.
Shimizu, W.: Arrhythmias originating from the right ventricular outflow tract: how to distinguish “malignant” from “benign”? Heart Rhythm, 2009, 6(10), 1507–1511.
Sinha, S., Calkins, H.: Idiopathic right ventricular outflow tract tachycardia: no longer idiopathic? J. Cardiovasc. Electrophysiol., 2006, 17(7), 776.
Tandri, H., Bluemke, D. A., Ferrari, V. A., et al.: Findings on magnetic resonance imaging of idiopathic right ventricular outflow tachycardia. Am. J. Cardiol., 2004, 94(11), 1441–1445.
Yamawake, N., Nishizaki, M., Hayashi, T., et al.: Autonomic and pharmacological responses of idiopathic ventricular tachycardia arising from the left ventricular outflow tract. J. Cardiovasc. Electrophysiol., 2007, 18(11), 1161–1166.
Yamada, T., Yoshida, N., Murakami, Y., et al.: Electrocardiographic characteristics of ventricular arrhythmias originating from the junction of the left and right coronary sinuses of Valsalva in the aorta: the activation pattern as a rationale for the electrocardiographic characteristics. Heart Rhythm, 2008, 5(2), 184–192.
Marcus, F. I., McKenna, W. J., Sherrill, D., et al.: Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation, 2010, 121(13), 1533–1541.
Hutchinson, M. D., Garcia, F. C.: An organized approach to the localization, mapping, and ablation of outflow tract ventricular arrhythmias. J. Cardiovasc. Electrophysiol., 2013, 24(10), 1189–1197.
Bogun, F., Taj, M., Ting, M., et al.: Spatial resolution of pace mapping of idiopathic ventricular tachycardia/ectopy originating in the right ventricular outflow tract. Heart Rhythm, 2008, 5(3), 339–344.
Shimoike, E., Ueda, N., Maruyama, T., et al.: Radiofrequency catheter ablation of upper septal idiopathic left ventricular tachycardia exhibiting left bundle branch block morphology. J. Cardiovasc. Electrophysiol., 2000, 11(2), 203–207.
Littmann, L., Kempler, P., Rohla, M., et al.: Ventricular tachycardia treated with verapamil. [Verapamillal kezelt kamrai tachycardia.] Orv. Hetil., 1988, 129(5), 247–250. [Hungarian]
Arya, A., Haghjoo, M., Emkanjoo, Z., et al.: Comparison of presystolic Purkinje and late diastolic potentials for selection of ablation site in idiopathic verapamil sensitive left ventricular tachycardia. J. Interv. Card. Electrophysiol., 2004, 11(2), 135–141.
Metzner, A., Ouyang, F., Wissner, E., et al.: Monomorphic and polymorphic ventricular tachycardias arising from the His-Purkinje system: what do we know? Future Cardiol., 2011, 7(6), 835–846.
Haïssaguerre, M., Shah, D. C., Jaïs, P., et al.: Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet, 2002, 359(9307), 677–678.
Gonzalez, R. P., Scheinman, M. M., Lesh, M. D., et al.: Clinical and electrophysiologic spectrum of fascicular tachycardias. Am. Heart J., 1994, 128(1), 147–156.
Tedrow, U., Stevenson, W. G.: Strategies for epicardial mapping and ablation of ventricular tachycardia. J. Cardiovasc. Electrophysiol., 2009, 20(6), 710–713.
Piers, S. R., de Riva Silva, M., M., Kapel, G. F., et al.: Endocardial or epicardial ventricular tachycardia in nonischemic cardiomyopathy? The role of 12-lead ECG criteria in clinical practice. Heart Rhythm, 2014, 11(6), 1031–1039.
Yamada, T.: Transthoracic epicardial catheter ablation: indications, techniques, and complications. Circ. J., 2013, 77(7), 1672–1680.
Bänsch, D., Oyang, F., Antz, M., et al.: Successful catheter ablation of electrical storm after myocardial infarction. Circulation, 2003, 108(24), 3011–3016.